On 2 November 2018, TU Delft spin-off BI/OND received the Accenture Innovation Award in the theme ‘Health’. Jury chairman Fenna Heyning, Director at STZ said the following about BI/OND:
“This year’s winner has proven that science can indeed make a difference. They are truly a learning organization. Yet as scientists, they risk staying unsung heroes. Winning today provides them the opportunity to realize their full potential and develop into a business, making their dreams come true.”
BI/OND empowers biologists with hardware solutions for cell-based assays. BI/OND’s customizable Organ-on-Chips (OOCs) are built to outperform the limitation of standard in vitro assays. In the early phase of drug testing, petri dishes and animals can fall short of predicting what happens inside the human body. To achieve accurate disease models and thus better medicine, it is fundamental to recreate human physiology and pathology. BI/OND offers unique hardware solutions for OOC applications that can be used to achieve this goal.
Read BI/OND’s entire portfolio